TuHURA Biosciences, Inc. HURA
1.61 USD -0.11 (-6.40%)
At closeNov 5, 2026, 4:00 PM EST
1.64 +0.03 +1.94%
After hours · Nov 5, 4:00 PM ET
1.56 Day range 1.80
0.41 52-week range 3.43
- YTD
- +112.68%
- 1 year
- -35.60%
- Market cap
- 102.60M
- EPS (ttm)
- -0.54
- Forward P/E
- -14.31
- YTD return
- +112.68%
- 1-year return
- -35.60%
- Volume
- 600.20K
- Avg volume
- 293.70K
- Open
- 1.73
- Previous close
- 1.72
- Day's range
- 1.56 – 1.80
- 52-week range
- 0.41 – 3.43
- Price target
- 15.00 (+831.7%)
- Earnings date
- Feb 12, 2025
5D -0.28 (-14.00%)
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 5.22
- 200-day average
- 6.16
Analyst view
Price target (mean) 15.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 12, 2025
Expected Feb 12, 2025. Consensus EPS estimate -0.09.
Financials — quick view
HURA Revenue — quarterly 0
HURA Net income — quarterly -9.22M
HURA EPS — quarterly -0.14
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 12, 2025 | Dec 1, 2024 | 0.00 | — | — | — |
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | -1.37 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 19, 2024 | Rodman & Renshaw | init | — | Buy |
News
TuHURA Biosciences Announces Three Presentations at the 68th American Society of Hematology Annual Meeting and Exposition 
HC Wainwright & Co. Reiterates Buy on TuHURA Biosciences, Maintains $10 Price Target - TuHURA Reports Initial Data Showing Partial Responses In First Three Metastatic Merkel Cell Carcinoma Patients Treated With Ifx-2.0 Plus Keytruda
12 Health Care Stocks Moving In Tuesday's After-Market Session 
TuHURA Biosciences Secures US Patent For TBS-2025, Entitled ‘Anti-VISTA Antibodies And Uses Thereof’
Your note
Sign in to keep a note on HURA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BIANCO JAMES A | Chief Executive Officer | Stock Award(Grant) | Oct 17, 2024 | 2,323,310 |
| HOFFMAN ROBERT E | Chief Executive Officer | Stock Award(Grant) | May 31, 2023 | 68,902 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Geode Capital Management, LLC | 0.06% | 25,394 | 105.39K | Sep 29, 2024 |
| Susquehanna International Group, LLP | 0.02% | 7,297 | 30.28K | Sep 29, 2024 |
| Nantahala Capital Management, LLC | 0.01% | 4,558 | 18.91K | Sep 29, 2024 |
| UBS Group AG | 0.01% | 5,930 | 24.61K | Sep 29, 2024 |
| Clear Creek Financial Management, LLC | 0.00% | 1,571 | 6.52K | Sep 29, 2024 |
| Baader Bank Aktiengesellschaft | 0.00% | 864 | 3.58K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.02% | 8,960 | 37.18K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.01% | 2,489 | 10.33K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.00% | 712 | 2.95K | Sep 29, 2024 |
| Fidelity Series Total Market Index Fund | 0.00% | 1,546 | 6.42K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.00% | 870 | 3.61K | Oct 30, 2024 |